the Effectiveness of 3rd Occipital Radiofrequency Versus Systemic Steroid in Headache Management in Rheumatoid Arthritis

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03852355
• Date of registration: 22/02/2019
• Prospective Registration: Yes
• Primary sponsor: Assiut University
• Public title: the Effectiveness of 3rd Occipital Radiofrequency Versus Systemic Steroid in Headache Management in Rheumatoid Arthritis
• Scientific title: the Effectiveness of 3rd Occipital Radiofrequency Versus Systemic Steroid in Headache Management in Rheumatoid Arthritis; a Randomized Controlled Trial
• Date of first enrolment: February 25, 2019
• Target sample size: 60
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03852355
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
• Phase: N/A

Countries of recruitment

Egypt

Key inclusion & exclusion criteria

Inclusion Criteria:

- patients suffering from upper neck pain and/or headache due to bilateral 3rd occipital
nerve involvement evidenced by magnetic resonance imaging (MRI).

Exclusion Criteria:

- disc herniation with radicular pain,

- symptomatic spinal stenosis,

- surgical interventions of the cervical spine within the last 3 months,

- uncontrolled major depression or psychiatric disorders,

- heavy opioid usage



Age minimum: 18 Years
Age maximum: 60 Years
Gender: All

Health Condition(s) or Problem(s) studied

Rheumatoid Arthritis

Headache

Intervention(s)

Drug: Radiofrequency

Drug: Steroids

Primary Outcome(s)

neck disability index score [Time Frame: 6 months]

Secondary Outcome(s)

Severity of headache Visual analog scale [Time Frame: 6 months]

Secondary ID(s)

IRB17300357

Source(s) of Monetary Support

Please refer to primary and secondary sponsors